Replies to post #123846 on Biotech Values

[mcbio]

CLDX: As long as we are talking about Hammer's picks, what do you guys think of that CLDX?

2 mid stage drugs that could work, and their APC technology (using antibodies to deliver antigens to dendrite cells).

Seams like a reasonable shot at $120M.

I personally like CLDX a lot and have been long for a little while. I bought in close to $4.50 so I'm a bit underwater but I am probably going to shortly sell off another position and double my CLDX holdings. Risk-reward seems quite interesting to me at current valuation. Note that market cap is actually closer to about $150M I believe after the recent offering.